Clinical Drug Experience Knowledgebase

22q11 Deletion Syndrome (Phase 3)

Acute Kidney Injury (Phase 3)

Atrophy (Phase 2)

Candidiasis (Phase 2)

Cardiac Output, Low (Phase 2)

Cardiomyopathies (Phase 2)

Cardiomyopathy, Dilated (Phase 2)

Fatty Liver (Phase 3)

Fibrosis (Phase 3)

Genetic Diseases, Inborn (Phase 2)

Graft vs Host Disease (Phase 2)

Heart Failure (Phase 2)

HIV Infections (Phase 1)

Homocystinuria (Phase 2)

Inflammation (Phase 3)

Insulin Resistance (Phase 3)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Liver Cirrhosis (Phase 3)

Liver Diseases (Phase 3)

Lymphoma, Non-Hodgkin (Phase 2)

Meningitis (Phase 2)

Metabolic Syndrome (Phase 3)

Muscular Atrophy (Phase 2)

Muscular Atrophy, Spinal (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Neonatal Sepsis (Phase 2)

Nephrosis (Phase 2)

Nephrotic Syndrome (Phase 2)

Neuroblastoma (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Preleukemia (Phase 2)

Renal Insufficiency (Phase 3)

Sepsis (Phase 2)

Spinal Muscular Atrophies of Childhood (Phase 2)

Status Epilepticus (Phase 3)

Syndrome (Phase 3)

Transposition of Great Vessels (Phase 2)